Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma
Launched by LV YINGJUAN · Aug 31, 2015
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • intraocular pressure greater than 22 mmHg with two or more medications
- • wide anterior chamber angle
- • glaucomatous optic neuropathy (Glaucomatous optic nerve damage was defined as cup-to-disc ratio higher than 0.7 or focal loss of the nerve fiber layer (notch) associated with a consistent glaucomatous visual field defect)
- • visual field loss consistent with optic nerve damage and visual fields were performed by using standard automated perimetry
- Exclusion Criteria:
- • the presence of any secondary glaucoma including exfoliation syndrome or a history of ocular trauma
- • high myopia
- • macular degeneration
- • other ocular diseases
- • a known history of systemic diseases and administration of vitamin D3 or other analog
About Lv Yingjuan
Lv Yingjuan is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a strong commitment to ethical practices and regulatory compliance, the organization specializes in designing and conducting clinical trials across various therapeutic areas. Leveraging a robust network of experienced professionals and cutting-edge technology, Lv Yingjuan aims to facilitate the efficient development of new treatments while ensuring the highest standards of safety and efficacy. Their collaborative approach fosters partnerships with healthcare institutions and research organizations, driving forward the mission of enhancing global health through scientific discovery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tianjin, Tianjin, China
Patients applied
Trial Officials
xiaorong li
Study Director
Tianjin Medical University Eye Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials